Our Polycystic Ovary Syndrome Screen combines a targeted selection of hormonal and metabolic markers to provide a thorough assessment of the key systems involved in PCOS. This profile measures circulating androgens—such as testosterone and related hormones—alongside indicators of ovulatory function, including Follicle-Stimulating Hormone (FSH), Luteinising Hormone (LH), and oestradiol. These insights help reveal whether hormonal imbalances are affecting ovarian activity, menstrual regularity, or the timing of ovulation.

In addition to reproductive hormones, the screen evaluates important metabolic markers that can be influenced by PCOS, particularly those related to insulin sensitivity and glucose regulation. Because metabolic health plays a central role in symptom development and long-term outcomes, this combined approach offers a more complete picture of how the condition may be impacting overall well-being.

All results are presented with clear clinical context, helping to identify patterns suggestive of PCOS, highlight areas of hormonal or metabolic concern, and determine whether further diagnostic steps may be appropriate. By integrating these findings, the Polycystic Ovary Syndrome Screen delivers a comprehensive foundation for personalised care, helping you understand your health more clearly and take proactive steps toward effective management and long-term balance.